Our Pricing

Orlistat vs Mounjaro: UK Registered Pharmacy Comparison

Published on: June 03, 2026

When comparing orlistat vs mounjaro uk pharmacy options, understanding the fundamental differences between these two MHRA-licensed weight loss treatments is essential for making an informed choice. Orlistat works by blocking fat absorption in your digestive system, while Mounjaro (tirzepatide) is a dual-action injectable that regulates appetite and blood sugar through hormone pathways. At Cured Pharmacy, our UK-registered clinical team can assess which treatment aligns with your medical history, weight loss goals, and lifestyle during a free online consultation.

How Orlistat and Mounjaro Work Differently

Orlistat is a lipase inhibitor that prevents approximately 30% of dietary fat from being absorbed in your intestines [1]. The unabsorbed fat passes through your digestive system, which means orlistat only works when you consume fat-containing meals. It's been available in the UK since 1998 and remains the only oral weight loss medication licensed for long-term use without injection.

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist approved by the MHRA for chronic weight management [2]. Unlike orlistat's mechanical action, tirzepatide works systemically by activating two incretin hormone pathways that regulate appetite, slow gastric emptying, and improve insulin sensitivity. This dual mechanism produces significantly greater weight reduction in clinical trials compared to single-pathway treatments.

Clinical Efficacy: Orlistat vs Mounjaro Weight Loss Results

In clinical trials, orlistat combined with a reduced-calorie diet produced an average weight loss of 5-10% of initial body weight over 12 months [1]. Patients typically lose 50% more weight with orlistat than with diet and exercise alone, making it a clinically proven option for those seeking moderate weight reduction.

Mounjaro demonstrates substantially greater efficacy in head-to-head comparisons. The SURMOUNT-1 trial showed patients on the 15mg maintenance dose achieved an average 22.5% body weight reduction over 72 weeks [2]. Even at the 5mg starting dose, average weight loss exceeded 15% — triple the typical results seen with orlistat therapy.

What the Trial Data Means for You

These percentage differences translate to meaningful real-world outcomes. A 100kg patient might expect to lose 5-10kg with orlistat over a year, compared to 15-22kg with Mounjaro at therapeutic doses [1][2]. However, individual results vary based on adherence, dietary changes, physical activity, and metabolic factors that your UK prescriber will assess during consultation.

Side Effect Profiles and Tolerability

Orlistat's side effects are directly related to its mechanism of blocking fat absorption. Common gastrointestinal effects include oily stools, increased bowel movements, flatulence with discharge, and faecal urgency [3]. These effects intensify when patients consume high-fat meals, which actually reinforces adherence to a lower-fat diet. Most patients find these effects manageable by limiting dietary fat intake to 15-20g per meal.

Mounjaro's side effects stem from its action on the gastrointestinal tract and include nausea, vomiting, diarrhoea, constipation, and decreased appetite [4]. These effects are typically most pronounced during the first few weeks and dose escalation periods. Approximately 5-10% of patients discontinue treatment due to gastrointestinal intolerance, though most find symptoms diminish with continued use.

Managing Side Effects in Clinical Practice

Our clinical team at Cured Pharmacy provides specific guidance on minimising side effects for both treatments. With orlistat, distributing fat intake evenly across meals and taking a multivitamin at bedtime helps prevent nutritional deficiencies. For Mounjaro patients, eating smaller portions, avoiding high-fat foods, and staying well-hydrated significantly reduces nausea and gastrointestinal discomfort during the initial treatment phase.

Dosing, Administration and Treatment Convenience

Orlistat requires taking one 120mg capsule with each main meal containing fat, up to three times daily [3]. If you skip a meal or eat a fat-free meal, you omit that dose. This dosing flexibility appeals to patients who prefer oral medication and want treatment that adapts to their eating patterns. The lower-strength 60mg formulation is available without prescription for patients with BMI 28-30.

Mounjaro is administered as a once-weekly subcutaneous injection using a pre-filled KwikPen. Treatment begins at 2.5mg weekly for four weeks, then increases to 5mg, with potential escalation to 7.5mg, 10mg, 12.5mg, or 15mg based on response and tolerability [4]. The weekly injection schedule offers convenience compared to daily treatments, though it does require patients to be comfortable with self-injection technique.

Suitability Criteria and Prescribing Guidelines

Orlistat is licensed for adults with BMI ≥30 kg/m², or BMI ≥28 kg/m² with weight-related comorbidities such as type 2 diabetes or hypertension [3]. It's often considered first-line pharmacotherapy due to its established safety profile, oral administration, and lower cost compared to injectable alternatives. Orlistat is contraindicated in chronic malabsorption syndrome, cholestasis, and pregnancy.

Mounjaro is indicated for adults with BMI ≥30 kg/m², or BMI ≥27 kg/m² with at least one weight-related comorbidity [4]. It's particularly suitable for patients who haven't achieved adequate weight loss with lifestyle modifications alone or who have concurrent type 2 diabetes. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease.

Clinical Assessment at Cured Pharmacy

During your online consultation, our UK prescribers evaluate your BMI, medical history, current medications, and weight loss goals to determine which treatment is clinically appropriate. Superintendent pharmacist Tarun Kumar (GPhC 2233073) and our clinical team consider factors including your previous weight loss attempts, dietary habits, injection tolerance, and any contraindications before recommending orlistat, Mounjaro, or alternative treatments available through our weight loss programme.

Cost Comparison and Treatment Value

Orlistat represents the most affordable prescription weight loss option at Cured Pharmacy, starting from £135.00 for a month's supply. This cost-effectiveness makes it accessible for patients seeking clinically proven weight loss support without the higher investment required for injectable treatments. Generic orlistat delivers identical efficacy to branded Xenical at a lower price point.

Mounjaro starts from £124.99 per month at Cured Pharmacy, reflecting the advanced pharmaceutical development and superior efficacy demonstrated in clinical trials [2]. While the upfront cost is higher, many patients find the significantly greater weight loss results and once-weekly convenience justify the investment. Our transparent pricing model shows exact costs before you complete your consultation, with no hidden fees or surprise charges.

Scientific References

1. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Orlistat 120mg Hard Capsules - Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. https://www.medicines.org.uk/emc/product/2592/smpc [accessed 13 August 2026]
4. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. https://www.medicines.org.uk/emc/product/14881/smpc [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and lifestyle changes. Cured Pharmacy is registered with the General Pharmaceutical Council (GPhC 9012511), with superintendent pharmacist Tarun Kumar (GPhC 2233073).